AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6 | -71.4% | 11,900 | -55.3% | 0.00% | -50.0% |
| Q4 2022 | $21 | -99.8% | 26,600 | +53.8% | 0.00% | +100.0% |
| Q3 2022 | $10,000 | +400.0% | 17,300 | +6.1% | 0.00% | – |
| Q2 2022 | $2,000 | -89.5% | 16,300 | -39.2% | 0.00% | -100.0% |
| Q1 2022 | $19,000 | +90.0% | 26,800 | +41.1% | 0.00% | – |
| Q4 2021 | $10,000 | +400.0% | 19,000 | +71.2% | 0.00% | – |
| Q2 2021 | $2,000 | -71.4% | 11,100 | -38.0% | 0.00% | – |
| Q1 2021 | $7,000 | +133.3% | 17,900 | +46.7% | 0.00% | – |
| Q3 2020 | $3,000 | -75.0% | 12,200 | -44.3% | 0.00% | -100.0% |
| Q2 2020 | $12,000 | -98.4% | 21,900 | -94.0% | 0.00% | -98.0% |
| Q1 2020 | $748,000 | – | 365,800 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 985,210 | $10,345,000 | 6.10% |
| Broadfin Capital, LLC | 3,568,122 | $37,465,000 | 5.54% |
| JW Asset Management, LLC | 444,439 | $4,667,000 | 3.42% |
| ARMISTICE CAPITAL, LLC | 1,688,000 | $17,724,000 | 2.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $38,383,000 | 1.73% |
| FALCON POINT CAPITAL, LLC | 661,490 | $6,284,000 | 0.91% |
| KNOTT DAVID M | 158,555 | $1,665,000 | 0.71% |
| Perceptive Advisors | 3,098,010 | $32,530,000 | 0.62% |
| Sio Capital Management, LLC | 91,413 | $960,000 | 0.50% |
| HEARTLAND ADVISORS INC | 700,000 | $7,350,000 | 0.48% |